European Heart Journal · 2001 · 18 citations · 0 references
PharmacyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacovigilanceAtherosclerotic Cardiovascular Disease PreventionCardiovascular Drug SafetyDrug Safety MonitoringDyslipidemia ManagementLong-term Efficacy AssessmentLong-term Efficacy EvaluationNonstatin Lipid-lowering TherapyPharmacokinetic Study DesignStatin Adverse Effects
Long-term efficacy and safety of rosuvastatin : results of a 52-week comparator-controlled trial versus atorvastatin